Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and Mekinist... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/ycIuu6C-tx0/novartis-gets-fda-breakthrough-status-for-tafinlar-mekinist-combination-idINKBN1CS0H1
Posted by Equitymaster After opening the day on a firm note, the Indian share markets �pared its morning gains to trade flat. Sectoral indices... ...http://www.equitymaster.com/tm/tm.asp?date=10/23/2017&title=Sensex-Pares-Gains-Telecom-Stocks-Rally
Oct 23 (Reuters) - Britain's FTSE 100 index isexpected to open 2 points higher at 7,525.5 on Monday, accordingto financial spreadbetters. * GSK:... ...http://www.sify.com/finance/uk-stocks-factors-to-watch-on-oct-23-news-economy-rkxltKafidjdb.html
(Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/Oc1GkP5klQQ/glaxosmithkline-adult-shingles-vaccine-wins-u-s-approval-idINKBN1CP2TF
(Reuters) - The head of the U.S. Food and Drug Administration said the agency was working with several pharmaceutical and medical device companies... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/bLeQ_TmqyzM/fda-teams-with-medical-companies-in-puerto-rico-to-tackle-shortages-idINKBN1CP23W
An additional reason precisely why...